| [1] |
Countouris M, Mahmoud Z, Cohen JB, et al. Hypertension in pregnancy and postpartum: current standards and opportunities to improve care[J]. Circulation,2025,151(7):490-507.
|
| [2] |
Silva WAd, Pinheiro AM, Lima PH, et al. Renal and cardiovascular repercussions in preeclampsia and their impact on fluid management: a literature review[J]. Braz J Anesthesiol,2021,71(4):421-428.
|
| [3] |
Ferreira RC, Fragoso MBT, Tenório MCDS, et al. Pre-eclampsia is associated with later kidney chronic disease and end-stage renal disease: systematic review and meta-analysis of observational studies[J]. Pregnancy Hypertens,2020,22:71-85.
|
| [4] |
Kountouris E, Clark K, Kay P, et al. Postnatal assessment for renal dysfunction in women with hypertensive disorders of pregnancy : a prospective observational study[J]. J Nephrol,2021,34(5):1641-1649.
|
| [5] |
Rodriguez AN, Nelson DB, Spong CY, et al. Acute kidney injury in pregnancies complicated by late-onset preeclampsia with severe features[J]. Am J Perinatol,2024,41(S1):e6-13.
|
| [6] |
Cabiddu G, Mannucci C, Fois A, et al. Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study[J]. Nephrol Dial Transplant,2022,37(8):1488-1498.
|
| [7] |
McDonald SD, Han Z, Walsh MW, et al. Kidney disease after preeclampsia: a systematic review and meta-analysis[J]. Am J Kidney Dis,2010,55(6):1026-1039.
|
| [8] |
Khashan AS, Evans M, Kublickas M, et al. Preeclampsia and risk of end stage kidney disease: a Swedish nationwide cohort study[J]. PLoS Med,2019,16(7):e1002875.
|
| [9] |
Behboudi-Gandevani S, Amiri M, Rahmati M, et al. Preeclampsia and the ten-year risk of incident chronic kidney disease[J]. Cardiorenal Med,2020,10(3):188-197.
|
| [10] |
Xue Y, Yang N, Gu X, et al. Risk prediction model of early-onset preeclampsia based on risk factors and routine laboratory indicators[J]. Life (Basel),2023,13(8):1648.
|
| [11] |
Denney JM, Bird C, Gendron-Fitzpatrick A, et al. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF[J]. Am J Physiol Renal Physiol,2017,312(3):F445-455.
|
| [12] |
Tsikouras P, Nikolettos K, Kotanidou S, et al. Renal function and the role of the renin-angiotensin-aldosterone system (RAAS) in normal pregnancy and pre-eclampsia[J]. J Clin Med,2025,14(3):892.
|
| [13] |
Bisson C, Dautel S, Patel E, et al. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum[J]. Front Med (Lausanne),2023,10:1144170.
|
| [14] |
Pankiewicz K, Szczerba E, Maciejewski T, et al. Non-obstetric complications in preeclampsia[J]. Prz Menopauzalny,2019,18(2):99-109.
|
| [15] |
Bakrania BA, Spradley FT, Drummond HA, et al. Preeclampsia: linking placental ischemia with maternal endothelial and vascular dysfunction[J]. Compr Physiol,2020,11(1):1315-1349.
|
| [16] |
Sinphitukkul K, Manotham K, Eiam-Ong S, et al. Aldosterone nongenomically induces angiotensin II receptor dimerization in rat kidney: role of mineralocorticoid receptor and NADPH oxidase[J]. Arch Med Sci,2019,15(6):1589-1598.
|
| [17] |
Kaleta T, Stock A, Panayotopoulos D, et al. Predictors of impaired postpartum renal function in women after preeclampsia: results of a prospective single center study[J]. Dis Markers,2016,2016:7861919.
|
| [18] |
胡蓉,李笑天. 如何预防子痫前期的严重不良结局[J/CD]. 中华产科急救电子杂志,2015,4(3): 150-153.
|
| [19] |
Shemies RS, Gaber TZ, Baiomy A, et al. Angiogenic markers predict kidney injury and obstetric complications in women with preeclampsia and pregnancy-related acute kidney injury[J]. Ther Apher Dial,2022,26(2):306-315.
|
| [20] |
Valsecchi L, Galdini A, Gabellini D, et al. Renal dysfunction and podocyturia in pre-eclampsia may be explained by increased urinary VEGF[J]. Nephrol Dial Transplant,2022,37(6):1109-1117.
|
| [21] |
Matsui M, Onoue K, Saito Y. sFlt-1 in chronic kidney disease: friend or foe?[J]. Int J Mol Sci,2022,23(22):14187.
|
| [22] |
Wewers TM, Schulz A, Nolte I, et al. Circulating soluble Fms-like tyrosine kinase in renal diseases other than preeclampsia[J]. J Am Soc Nephrol,2021,32(8):1853-1863.
|
| [23] |
Marco GSD, Reuter S, Hillebrand U, et al. The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD[J]. J Am Soc Nephrol,2009,20(10):2235-2245.
|
| [24] |
Thitivichienlert T, Phaloprakarn C, Trakarnvanich T. Long-term observational study of renal outcome after preeclampsia: role of soluble fms-like tyrosine kinase-1(sFlt-1)/ placental growth factor (PlGF) and endoglin[J]. Ann Med Surg (Lond), 2022,78:103818.
|
| [25] |
中华医学会妇产科学分会妊娠期高血压疾病学组,中华医学会围产医学分会. 子痫前期预测与预防指南(2025)[J]. 中华妇产科杂志,2025,60(5):329-342.
|
| [26] |
Bianchi G, Vogt B, Bargagli M, et al. The dilemma of chronic kidney disease and end-stage kidney disease following pre-eclampsia: a literature review and meta-analysis[J]. Int Urol Nephrol,2025,57(12):4131-4140.
|
| [27] |
Covella B, Vinturache AE, Cabiddu G, et al. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia[J]. Kidney Int,2019,96(3):711-727.
|
| [28] |
National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management[EB/OL]. (2023-04-17)[2025-07-07].
URL
|
| [29] |
Sharma M, Mazumder MA, Alam S, et al. Characteristics, maternal and neonatal outcomes of acute kidney injury in preeclampsia: a prospective, single-center study[J]. Clin Nephrol,2021,96(5):263-269.
|
| [30] |
Wang M, Chen S, He Y, et al. Low-dose aspirin for the prevention of severe preeclampsia in patients with chronic kidney disease: a retrospective study: This is the study for kidney and pregnancy[J]. J Nephrol,2021,34(5):1631-1639.
|
| [31] |
Lin J, Cao X, Fu W, et al. Effect of low-dose aspirin on reducing cardiovascular events and mortality in individuals with CKD stages 3-5: a meta-analysis of randomized controlled trials[J]. BMC Cardiovasc Disord,2025,25(1):242.
|